Strategic Investment
Member Login   RSS ->
[Picture: James Davidson]

Issues

[PDF] Better Than The Lottery. . .
On June 2, GT Biopharma (GTBP) closed at a 52-week high of $18.96, giving you an unrealized profit of $14.88 per share or $109,412.64 per the Strategic Investment recommendation.
(June 2021)

More Issues

Special Reports

[PDF] How to Profit From WTER
As health consciousness trends keep increasing, consumers are opting for healthier choices. Consumers have been switching is to more available water options and away from sugary drinks.
(May 28, 2021)

More Special Reports

Alerts

We Are Taking Some Profits!
We are tiding up our portfolio for a modest profit of $4,393
(#032: February 19, 2021)

More Alerts

Updates

Are You Watching GTBP?
The GT Biopharma position we have been writing about since 2018 is producing terrific results.
(#009: May 28, 2021)

More Updates

Feedback

Use our contact form to send feedback; choose "Editor" in the pulldown menu. Your feedback and the editor's response may be posted here.

More Feedback

Offers